10 Affordable Biotech Stocks to Buy Right Now
In this article, we will take a look at some of the most affordable biotech stocks that are currently offering attractive upside potential.
Tango Therapeutics Inc. (TNGX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 12,277,000 | $383,779,020 | +35% | 1.77% |
| 2. | Boxer Capital Aaron Davis And Christopher Fuglesang | 10,876,219 | $339,990,606 | 25.61% | |
| 3. | Paradigm Biocapital Advisors Senai Asefaw | 6,357,523 | $198,736,169 | +59% | 3.72% |
| 4. | Siren L.L.C. Raymond Debbane | 6,179,364 | $193,166,919 | +10% | 3.91% |
| 5. | Adage Capital Management Phill Gross And Robert Atchinson | 5,600,000 | $175,056,000 | -57% | 0.25% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.78 | 10,000 | $37,800.00 | 31,250 | 2024-11-18 | Filing | |
| $3.62 | 10,000 | $36,200.00 | 21,250 | 2024-11-14 | Filing | |
| $6.84 | 500,000 | $3,420,000.00 | 8,198,642 | 2023-10-16 | Filing | |
| $7.07 | 750,000 | $5,302,500.00 | 7,698,642 | 2023-10-13 | Filing | |
| $6.84 | 500,000 | $3,420,000.00 | 8,198,642 | 2023-10-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.37 | 27,000 | $603,909.00 | 115,743 | 2026-09-01 | Filing | |
| $27.35 | 21,733 | $594,417.11 | 115,743 | 2026-08-03 | Filing | |
| $26.79 | 5,267 | $141,100.30 | 137,476 | 2026-08-03 | Filing | |
| $30.25 | 7,371 | $222,946.21 | 115,743 | 2026-07-01 | Filing | |
| $29.34 | 19,629 | $575,961.97 | 123,114 | 2026-07-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,900,620 | $434,533,381 | 3.71% | |
| 2. | 12,438,444 | $388,825,760 | 0.01% | |
| 3. | 12,333,339 | $385,540,161 | 0.02% | |
| 4. | 9,980,620 | $311,994,191 | 0.03% | |
| 5. | 9,081,201 | $283,878,343 | 6.82% |
News See All
10 Most Promising Mid-Cap Healthcare Stocks According to Hedge Funds
In this article, we will take a look at some of the best mid-cap healthcare stocks that are being highly favored by hedge funds.
Stifel Remains Bullish on Tango Therapeutics (TNGX)
Tango Therapeutics, Inc. (NASDAQ:TNGX) is one of the best performing healthcare stocks so far in 2026. Stifel lifted the price target on Tango Therapeutics, Inc.
10 Best Performing Healthcare Stocks So Far in 2026
In this article, we will look at the 10 Best Performing Healthcare Stocks So Far in 2026.
10 Best Performing Stocks of Q1 2026 to Watch for Q2
In this article, we will be looking at the 10 Best Performing Stocks of Q1 2026 to Watch for Q2.
Tango Therapeutics' (TNGX) Sees Cautious Analyst Optimism Following Earnings
Tango Therapeutics Inc. (NASDAQ:TNGX) is one of the 11 Best Day Trading Stocks to Buy Now. Financial firm Mizuho raised its share price target for Tango Therapeutics Inc. (NASDAQ:TNGX) on March 11th.
11 Best Day Trading Stocks to Buy Now
In this article, we will discuss: 11 Best Day Trading Stocks to Buy Now.
Wedbush Reaffirms Outperform Rating for Tango Therapeutics (TNGX)
Tango Therapeutics Inc. (NASDAQ:TNGX) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On March 6, Wedbush increased the firm’s price target on Tango Therapeutics Inc.
10 Most Shorted Biotech Stocks to Buy According to Hedge Funds
On February 5, J.P. Morgan shared its views on trends that are expected to define healthcare in 2026.
Tango Therapeutics (TNGX) Soars 52% on Buy Reco
Tango Therapeutics Inc. (NASDAQ:TNGX) is one of the 10 Stocks Investors Are Watching Closely This Week.
Hedge Fund Resource Center